{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:45:16Z","timestamp":1769165116803,"version":"3.49.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":549,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>The rationale for screening inflammatory serum biomarkers of the hepatic vein pressure gradient (HVPG) is based on the fact that portal hypertension is pathogenically related to liver injury and fibrosis, and that in turn these are associated with the activation of inflammatory pathways. This was a nested cohort study in the setting of a randomized, clinical trial to assess the development of gastroesophageal varices (GEV) (N Engl J Med 2005;353:2254). Patients had cirrhosis and portal hypertension but did not have GEV. A total of 90 patients who had baseline day-1 sera available were enrolled in the present study. The objective of this study was to determine whether inflammatory biomarkers in conjunction with clinical parameters could be used to develop a predictive paradigm for HVPG. The correlations between HVPG and interleukin (IL)-1\u03b2 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0052); IL-1R-\u03b1 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0085); Fas-R (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0354), and serum VCAM-1 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0007) were highly significant. By using multivariate logistic regression analysis and selected parameters (transforming growth factor beta [TGF\u03b2]; heat shock protein [HSP]-70; at-risk alcohol use; and Child class B) we could exclude HVPG \u226512 mmHg with 86% accuracy (95% confidence interval [CI]: 67.78 to 96.16%) and the sensitivity was 87.01% (95% CI: 69.68 to 96.34%). Therefore, the composite test could identify 86% of compensated cirrhosis patients with HVPG below 12 mmHg and prevent unnecessary esophagogastroduodenoscopy with its associated morbidity and costs in these patients. Our diagnostic test was not efficient in predicting HVPG \u226512 mmHg. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: A blood test for HVPG could be performed in cirrhosis patients to prevent unnecessary esophagogastroduodenoscopy. (HEPATOLOGY 2014;59:1052\u20131059)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26755","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T01:29:34Z","timestamp":1381541374000},"page":"1052-1059","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":66,"title":["Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients"],"prefix":"10.1097","volume":"59","author":[{"given":"Martina","family":"Buck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto J.","family":"Groszmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Stalling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman D.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew K.","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Patch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Matloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Clopton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Chojkier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-34-20250207","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2008-1040318","article-title":"Portal hypertension and gastrointestinal bleeding.","volume":"28","author":"Bosch","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R3-34-20250207","doi-asserted-by":"crossref","first-page":"14011407","DOI":"10.1016\/0016-5085(90)91168-6","article-title":"Hemodynamic events in a prospective randomized trial of propranolol vs placebo in the prevention of the first variceal hemorrhage.","volume":"99","author":"Groszmann","year":"1990","journal-title":"Gastroenterology"},{"key":"R4-34-20250207","doi-asserted-by":"crossref","first-page":"425427","DOI":"10.1136\/gut.50.3.425","article-title":"Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?","volume":"50","author":"Burroughs","year":"2002","journal-title":"Gut"},{"key":"R5-34-20250207","doi-asserted-by":"crossref","first-page":"536538","DOI":"10.1016\/j.cgh.2011.04.013","article-title":"Patients with clinically significant portal hypertension caused by hepatitis C virus cirrhosis respond poorly to antiviral therapy.","volume":"9","author":"Grace","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-34-20250207","doi-asserted-by":"crossref","first-page":"245248","DOI":"10.1002\/hep.510250145","article-title":"Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis?","volume":"25","author":"Armonis","year":"1997","journal-title":"Hepatology"},{"key":"R8-34-20250207","doi-asserted-by":"crossref","first-page":"29052909","DOI":"10.1111\/j.1572-0241.2000.03202.x","article-title":"Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis.","volume":"95","author":"Schepke","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R9-34-20250207","doi-asserted-by":"crossref","first-page":"696703","DOI":"10.1016\/j.jhep.2011.07.005","article-title":"Non invasive evaluation of portal hypertension using transient elastography.","volume":"56","author":"Castera","year":"2012","journal-title":"J Hepatol"},{"key":"R10-34-20250207","doi-asserted-by":"crossref","first-page":"20442052","DOI":"10.1002\/hep.23918","article-title":"Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.","volume":"52","author":"Bellot","year":"2010","journal-title":"Hepatology"},{"key":"R13-34-20250207","doi-asserted-by":"crossref","first-page":"978985","DOI":"10.1002\/hep.22083","article-title":"Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.","volume":"47","author":"Frances","year":"2008","journal-title":"Hepatology"},{"key":"R15-34-20250207","doi-asserted-by":"crossref","first-page":"364369","DOI":"10.1016\/S0168-8278(94)80009-X","article-title":"Correlations between sinusoidal pressure and liver morphology in cirrhosis.","volume":"20","author":"Picchiotti","year":"1994","journal-title":"J Hepatol"},{"key":"R18-34-20250207","doi-asserted-by":"crossref","first-page":"482487","DOI":"10.1002\/hep.1840100414","article-title":"Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations.","volume":"10","author":"Valla","year":"1989","journal-title":"Hepatology"},{"key":"R20-34-20250207","first-page":"229254","article-title":"The interleukin1 receptor family.","volume":"74","author":"Boraschi","year":"2006","journal-title":"Vitam Horm"},{"key":"R21-34-20250207","doi-asserted-by":"crossref","first-page":"778780","DOI":"10.1038\/nm0707-778","article-title":"IL1alpha responds to necrotic cell death.","volume":"13","author":"Elkon","year":"2007","journal-title":"Nat Med"},{"key":"R22-34-20250207","doi-asserted-by":"crossref","first-page":"419428","DOI":"10.1002\/hep.24747","article-title":"A phase 2, randomized, doubleblind, placebocontrolled study of GS9450 in subjects with nonalcoholic steatohepatitis.","volume":"55","author":"Ratziu","year":"2012","journal-title":"Hepatology"},{"key":"R23-34-20250207","doi-asserted-by":"crossref","first-page":"21768214","DOI":"10.1002\/eji.201041034","article-title":"Negative regulation of signaling by a soluble form of tolllike receptor 9.","volume":"41","author":"Chockalingam","year":"2011","journal-title":"Eur J Immunol"},{"key":"R24-34-20250207","doi-asserted-by":"crossref","first-page":"241247","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase1activation platform that regulates immune responses and disease pathogenesis.","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat Immunol"},{"key":"R25-34-20250207","doi-asserted-by":"crossref","first-page":"505513","DOI":"10.1016\/j.immuni.2011.01.018","article-title":"Granulin is a soluble cofactor for tolllike receptor 9 signaling.","volume":"34","author":"Park","year":"2011","journal-title":"Immunity"},{"key":"R26-34-20250207","doi-asserted-by":"crossref","first-page":"57ra82","DOI":"10.1126\/scitranslmed.3001510","article-title":"TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.","volume":"2","author":"Trujillo","year":"2010","journal-title":"Sci Transl Med"},{"key":"R27-34-20250207","doi-asserted-by":"crossref","first-page":"295308","DOI":"10.1016\/j.ccr.2009.08.021","article-title":"A lymphotoxindriven pathway to hepatocellular carcinoma.","volume":"16","author":"Haybaeck","year":"2009","journal-title":"Cancer Cell"},{"key":"R28-34-20250207","doi-asserted-by":"crossref","first-page":"475484","DOI":"10.1016\/j.molcel.2005.06.015","article-title":"Regulation of Fas alternative splicing by antagonistic effects of TIA1 and PTB on exon definition.","volume":"19","author":"Izquierdo","year":"2005","journal-title":"Mol Cell"},{"key":"R29-34-20250207","doi-asserted-by":"crossref","first-page":"16351636","DOI":"10.1126\/science.1071553","article-title":"The Fas signaling pathway: more than a paradigm.","volume":"296","author":"Wajant","year":"2002","journal-title":"Science"},{"key":"R30-34-20250207","doi-asserted-by":"crossref","first-page":"H2344H2354","DOI":"10.1152\/ajpheart.00432.2007","article-title":"Homocysteine induces VCAM1 gene expression through NFkappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants.","volume":"293","author":"Carluccio","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R31-34-20250207","doi-asserted-by":"crossref","first-page":"34313437","DOI":"10.4049\/jimmunol.161.7.3431","article-title":"Mechanisms of hyaluronaninduced upregulation of ICAM1 and VCAM1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factorkappa B and activating protein1.","volume":"161","author":"Oertli","year":"1998","journal-title":"J Immunol"},{"key":"R32-34-20250207","doi-asserted-by":"crossref","first-page":"645651","DOI":"10.1161\/01.ATV.20.3.645","article-title":"Angiotensin II stimulates endothelial vascular cell adhesion molecule1 via nuclear factorkappaB activation induced by intracellular oxidative stress.","volume":"20","author":"Pueyo","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R33-34-20250207","doi-asserted-by":"crossref","first-page":"191197","DOI":"10.1111\/j.1478-3231.2009.02132.x","article-title":"A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension.","volume":"30","author":"Abdelmoneim","year":"2010","journal-title":"Liver Int"},{"key":"R34-34-20250207","doi-asserted-by":"crossref","first-page":"10461055","DOI":"10.1002\/hep.20665","article-title":"Systemic infusion of angiotensin II exacerbates liver fibrosis in bile ductligated rats.","volume":"41","author":"Bataller","year":"2005","journal-title":"Hepatology"},{"key":"R35-34-20250207","first-page":"12691277","article-title":"Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation.","volume":"77","author":"BosyWestphal","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R36-34-20250207","first-page":"638642","article-title":"Increased serum levels of hyaluronate in liver disease.","volume":"5","author":"EngstromLaurent","year":"1985","journal-title":"Hepatology"},{"key":"R37-34-20250207","first-page":"1222","article-title":"Induction of TIMP1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis.","volume":"1455","author":"Torres","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"R38-34-20250207","doi-asserted-by":"crossref","first-page":"490497","DOI":"10.4049\/jimmunol.166.1.490","article-title":"Characterization of heat shock protein 110 and glucoseregulated protein 170 as cancer vaccines and the effect of feverrange hyperthermia on vaccine activity.","volume":"166","author":"Wang","year":"2001","journal-title":"J Immunol"},{"key":"R39-34-20250207","doi-asserted-by":"crossref","first-page":"4040040413","DOI":"10.1074\/jbc.M112.410712","article-title":"Glutaminemediated dual regulation of heat shock transcription factor1 activation and expression.","volume":"287","author":"Xue","year":"2012","journal-title":"J Biol Chem"},{"key":"R40-34-20250207","doi-asserted-by":"crossref","first-page":"12901297","DOI":"10.1002\/hep.21665","article-title":"Liver stiffness measurement predicts severe portal hypertension in patients with HCVrelated cirrhosis.","volume":"45","author":"Vizzutti","year":"2007","journal-title":"Hepatology"},{"key":"R41-34-20250207","doi-asserted-by":"crossref","first-page":"828835","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: a 5year prospective study of 13,369 examinations.","volume":"51","author":"Castera","year":"2010","journal-title":"Hepatology"},{"key":"R42-34-20250207","doi-asserted-by":"crossref","first-page":"17051713","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"R43-34-20250207","doi-asserted-by":"crossref","first-page":"e58742","DOI":"10.1371\/journal.pone.0058742","article-title":"Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension.","volume":"8","author":"Berzigotti","year":"2013","journal-title":"PLoS One"},{"key":"R45-34-20250207","doi-asserted-by":"crossref","first-page":"555561","DOI":"10.1002\/hep.24418","article-title":"Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.","volume":"54","author":"Berzigotti","year":"2011","journal-title":"Hepatology"},{"key":"R46-34-20250207","doi-asserted-by":"crossref","first-page":"646654","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCVrelated cirrhosis.","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology"},{"key":"R47-34-20250207","doi-asserted-by":"crossref","first-page":"11011107","DOI":"10.1038\/ajg.2013.119","article-title":"Spleen stiffness in patients with cirrhosis in predicting esophageal varices.","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26755","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201403000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:59:01Z","timestamp":1738947541000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201403000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26755","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}